| Pharmacovigilance Programme of India: Recent developments and future perspectives V Kalaiselvan, P Thota, GN Singh Indian journal of pharmacology 48 (6), 624-628, 2016 | 123 | 2016 |
| An overview of statins as hypolipidemic drugs K Srinivasa Rao, T Prasad, GP Mohanta, PK Manna IJPSDR 3 (3), 178-83, 2011 | 80 | 2011 |
| Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review A Bhattacharyya, P Sarma, DJ Sharma, KK Das, H Kaur, M Prajapat, ... Indian journal of pharmacology 53 (4), 317-327, 2021 | 68 | 2021 |
| Adverse drug reactions reporting culture in Pharmacovigilance Programme of India V Kalaiselvan, T Prasad, A Bisht, S Singh, GN Singh Indian Journal of Medical Research 140 (4), 563-564, 2014 | 56 | 2014 |
| COVID-19–associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis A Bhattacharyya, P Sarma, H Kaur, S Kumar, J Bhattacharyya, M Prajapat, ... Indian Journal of Pharmacology 53 (6), 499-510, 2021 | 39 | 2021 |
| Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review H Kaur, P Sarma, A Bhattacharyya, S Sharma, N Chhimpa, M Prajapat, ... European journal of pharmacology 906, 174233, 2021 | 31 | 2021 |
| Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis P Sarma, A Bhattacharyya, H Kaur, M Prajapat, A Prakash, S Kumar, ... Indian journal of pharmacology 52 (6), 535-550, 2020 | 29 | 2020 |
| Materiovigilance programme of India (MVPI): A step towards patient safety for medical devices P Kumar, V Kalaiselvan, I Kaur, P Thota, GN Singh Eur J Biomed Pharm Sci 12 (7), 497-501, 2016 | 28 | 2016 |
| Status of documentation grading and completeness score for Indian individual case safety reports K Vivekanandan, K Rishi, T Prasad, T Arunabh, GN Singh Indian journal of pharmacology 47 (3), 325-327, 2015 | 26 | 2015 |
| Current status of adverse drug reactions monitoring centres under pharmacovigilance programme of India V Kalaiselvan, P Thota, A Singh Indian Journal of Pharmacy Practice 7 (3), 2014 | 25 | 2014 |
| Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India P Thota, A Thota, B Medhi, S Sidhu, P Kumar, VK Selvan, GN Singh Perspectives in clinical research 9 (1), 51-55, 2018 | 19 | 2018 |
| Indian contribution toward biomedical research and development in COVID-19: A systematic review H Kaur, M Kaur, A Bhattacharyya, M Prajapat, P Thota, P Sarma, S Kumar, ... Indian Journal of Pharmacology 53 (1), 63-72, 2021 | 16 | 2021 |
| Quantitative methods for the identification of signals for individual case safety reports in India K Vivekanandan, A Tripathi, A Saurabh, R Kumar, R Kumar, T Prasad, ... Therapeutic innovation & regulatory science 49 (6), 898-902, 2015 | 13 | 2015 |
| Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India V Agrawal, TP Shrivastava, PK Adusumilli, K Vivekanandan, P Thota, ... Perspectives in clinical research 10 (3), 140-144, 2019 | 12 | 2019 |
| Therapeutic options for management of Hori's nevus: A systematic review H Kaur, P Sarma, S Kaur, H Kaur, M Prajapat, S Mahendiratta, S Kumar, ... Dermatologic therapy 33 (1), e13167, 2020 | 9 | 2020 |
| Weight gain in association with insulin use—an analysis of individual case safety reports an Indian database P Thota, K Vivekanandan, J Prakash, S Singh, GN Singh J Pharmacovigil 2, 119, 2014 | 7 | 2014 |
| Identification of Potent Bioassay Guided Terpenoid and Glycoside Root Fractions of Astragalus candolleanus against Clinically Significant Bacterial Strains Kandasamy Nagarajan, Roma Ghai, Garima Varshney, Parul Grover , Carlo ... International journal of Microbiology 2022 (https://www.hindawi.com/journals …, 2022 | 6 | 2022 |
| Cefixime-associated acute generalized exanthematous pustulosis: Rare cases in India V Kumar, V Kalaiselvan, AP Kumar, A Saurabh, P Thota, S Sidhu, ... Indian Journal of Pharmacology 50 (4), 204-207, 2018 | 6 | 2018 |
| pharmacovigilates in pharmacovigilance programme of india ideal qualities and skills GNS Kalaiselvan V, Prasad Thota, Vijay Venkatraman J Journal of Young Pharmacists 8 (3), 291-292, 2016 | 6* | 2016 |
| Spontaneous reporting of adverse drug reactions in geriatric patients in India V Kalaiselvan, S Gakhar, P Thota, SK Gupta, GN Singh National Journal of Physiology, Pharmacy and Pharmacology 4 (3), 225, 2014 | 6 | 2014 |
